Security Snapshot

FEMASYS INC - Common Stock, par value $0.0001 per share (FEMY) Institutional Ownership

CUSIP: 31447E105

13F Institutional Holders and Ownership History from Q2 2021 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

37

Shares (Excl. Options)

3,527,637

Price

$0.58

Type / Class
Equity / Common Stock, par value $0.0001 per share
Symbol
FEMY on Nasdaq
Shares outstanding
62,678,844
Price per share
$0.40
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
3,527,637
Total reported value
$2,032,737
% of total 13F portfolios
0%
Share change
+1,504,340
Value change
+$892,676
Number of holders
37
Price from insider filings
$0.40
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Sponsored

Quick Takeaways

  • FEMY - FEMASYS INC - Common Stock, par value $0.0001 per share is tracked under CUSIP 31447E105.
  • 37 institutions reported positions in Q4 2025.
  • 4 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 37 to 1 between Q4 2025 and Q1 2026.
  • Reported value moved from $2,032,737 to $6,000.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Official SEC Source

Backed by Form 13F

Ownership context comes from SEC Form 13F and, when available, Schedule 13D/13G filings.

See Original Filing

Investment Quick Answers

What is CUSIP 31447E105?
CUSIP 31447E105 identifies FEMY - FEMASYS INC - Common Stock, par value $0.0001 per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of FEMASYS INC - Common Stock, par value $0.0001 per share (FEMY) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PharmaCyte Biotech, Inc. 7.9% $2,762,382 4,932,825 PharmaCyte Biotech, Inc. 17 Mar 2026
Alumni Capital LP 10% $3,866,599 4,773,579 Alumni Capital LP 04 Sep 2025
Dauntless Investment Group, LLC 9.9% +90% $1,549,149 +$1,045,272 4,395,996 +207% Dauntless Investment Group, LLC 30 Sep 2025
Chernett Jorey 9.3% +52% $2,930,561 +$1,361,799 3,034,335 +87% Chernett Jorey 30 Jun 2025

As of 31 Dec 2025, 37 institutional investors reported holding 3,527,637 shares of FEMASYS INC - Common Stock, par value $0.0001 per share (FEMY). This represents 5.6% of the company’s total 62,678,844 outstanding shares.

Institutional Holders of FEMASYS INC - Common Stock, par value $0.0001 per share (FEMY) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 15,000 $6,000 $0.40 1
2025 Q4 3,527,637 $2,032,737 +$892,676 $0.58 37
2025 Q3 3,739,959 $1,316,955 -$688,242 $0.35 31
2025 Q2 2,806,752 $2,709,104 +$451,125 $0.97 35
2025 Q1 3,903,741 $4,879,295 +$1,890,698 $1.25 30
2024 Q4 2,385,879 $2,624,495 +$784,707 $1.10 29
2024 Q3 1,672,303 $1,856,384 +$34,980 $1.11 27
2024 Q2 1,639,679 $1,868,650 +$122,478 $1.14 28
2024 Q1 1,521,808 $2,358,654 +$126,161 $1.55 23
2023 Q4 1,476,749 $1,440,174 -$2,263,713 $0.98 24
2023 Q3 1,648,910 $5,724,136 +$239,815 $2.98 27
2023 Q2 1,189,769 $3,176,795 +$2,570,143 $0.51 20
2023 Q1 1,189,709 $1,263,455 +$168,111 $1.08 16
2022 Q4 987,996 $889,424 +$85,672 $0.90 16
2022 Q3 884,106 $999,000 +$4,354 $1.13 15
2022 Q2 821,662 $1,979,647 +$39,372 $2.41 16
2022 Q1 817,819 $1,847,000 +$588,503 $2.26 14
2021 Q4 515,082 $2,008,000 -$751,831 $3.90 13
2021 Q3 522,946 $3,605,000 -$707,281 $6.89 9
2021 Q2 601,218 $4,904,864 +$4,904,864 $8.11 11

Sponsored